These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23406664)

  • 21. Venous endotelin-1 (ET-1) and brain natriuretic peptide (BNP) plasma levels during 6-month bosentan treatment for pulmonary arterial hypertension.
    Vizza CD; Letizia C; Petramala L; Badagliacca R; Poscia R; Zepponi E; Crescenzi E; Nona A; Benedetti G; Ferrante F; Sciomer S; Fedele F
    Regul Pept; 2008 Nov; 151(1-3):48-53. PubMed ID: 18796317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of systemic and pulmonary arterial remodelling in women with systemic sclerosis.
    Irzyk K; Bienias P; Rymarczyk Z; Bartoszewicz Z; Siwicka M; Bielecki M; Karpińska A; Dudzik-Niewiadomska I; Pruszczyk P; Ciurzyński M
    Scand J Rheumatol; 2015; 44(5):385-8. PubMed ID: 25928303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-terminal pro-brain natriuretic peptide in systemic sclerosis: new insights.
    Elshamy HA; Ibrahim SE; Farouk HM; Moustafa AA; Aly IM; Osman WM
    Eur J Dermatol; 2011; 21(5):686-90. PubMed ID: 21700537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary and ventricular functions in children with repaired tetralogy of Fallot.
    Demirpençe S; Güven B; Yılmazer MM; Öner T; Doksöz Ö; Özdemir R; Nacaroğlu HT; Meşe T; Tavlı V; Can D
    Turk Kardiyol Dern Ars; 2015 Sep; 43(6):542-50. PubMed ID: 26363747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exercise testing can unmask right ventricular dysfunction in systemic sclerosis patients with normal resting pulmonary artery pressure.
    Chia EM; Lau EM; Xuan W; Celermajer DS; Thomas L
    Int J Cardiol; 2016 Feb; 204():179-86. PubMed ID: 26681539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Six-minute walk test for the evaluation of pulmonary disease severity in scleroderma patients.
    Villalba WO; Sampaio-Barros PD; Pereira MC; Cerqueira EM; Leme CA; Marques-Neto JF; Paschoal IA
    Chest; 2007 Jan; 131(1):217-22. PubMed ID: 17218579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
    Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
    J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severity of systemic sclerosis-associated pulmonary arterial hypertension in African Americans.
    Blanco I; Mathai S; Shafiq M; Boyce D; M Kolb T; Chami H; K Hummers L; Housten T; Chaisson N; L Zaiman A; M Wigley F; J Tedford R; A Kass D; Damico R; E Girgis R; M Hassoun P
    Medicine (Baltimore); 2014 Jul; 93(5):177-185. PubMed ID: 25181310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum interleukin-6 in systemic sclerosis and its correlation with disease parameters and cardiopulmonary involvement.
    Abdel-Magied RA; Kamel SR; Said AF; Ali HM; Abdel Gawad EA; Moussa MM
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):321-330. PubMed ID: 28079844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The six-minute walk test using forehead oximetry is reliable in the assessment of scleroderma lung disease.
    Wilsher M; Good N; Hopkins R; Young P; Milne D; Gibson A; Suppiah R; Ly J; Doughty R; Dalbeth N
    Respirology; 2012 May; 17(4):647-52. PubMed ID: 22256786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC; Highland KB; Silver RM; Strange C
    J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance capacity evaluated using the 6-minute walk test: 5-year results in patients with diffuse systemic sclerosis and initial interstitial lung disease.
    Rizzi M; Sarzi-Puttini P; Airoldi A; Antivalle M; Battellino M; Atzeni F
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S142-7. PubMed ID: 26339893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors relating to impaired stroke volume during the 6-minute walk test in patients with systemic sclerosis.
    Someya F; Mugii N; Oohata S
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):152-156. PubMed ID: 27463117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of right ventricular dysfunction on exercise capacity and quality of life and associations with serum NT-proBNP levels in COPD: an observational study.
    Ozdemirel TS; Ulaşli SS; Yetiş B; Karaçağlar E; Bayraktar N; Ulubay G
    Anadolu Kardiyol Derg; 2014 Jun; 14(4):370-7. PubMed ID: 24818627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of right ventricular functions and B-type natriuretic peptide levels by cardiopulmonary exercise test in patients with pulmonary regurgitation after repair of tetralogy of Fallot.
    Cetin I; Tokel K; Varan B; Orün UA; Gökdemir M; Cindik N; Eyüboğlu F; Ulubay G; Aşlamaci S
    J Card Surg; 2008; 23(5):493-8. PubMed ID: 18928486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relation of Right Atrial Mechanics to Functional Capacity in Patients With Systemic Sclerosis.
    Nógrádi Á; Porpáczy A; Porcsa L; Minier T; Czirják L; Komócsi A; Faludi R
    Am J Cardiol; 2018 Oct; 122(7):1249-1254. PubMed ID: 30082039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Declining cardiopulmonary exercise capacity is not associated with worsening systolic systemic ventricular dysfunction in adults with transposition of great arteries after atrial switch operation.
    Roentgen P; Kaan M; Tutarel O; Meyer GP; Westhoff-Bleck M
    Congenit Heart Dis; 2014; 9(3):259-65. PubMed ID: 24034170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reproducibility and Utility of the 6-minute Walk Test in Systemic Sclerosis.
    Pugnet G; Marjanovic Z; Deligny C; Boussardon K; Benzidia I; Puyade M; Lansiaux P; Vandecasteele E; Smith V; Farge D
    J Rheumatol; 2018 Aug; 45(9):1273-1280. PubMed ID: 29961695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced Right Ventricular Output Reserve in Patients With Systemic Sclerosis and Mildly Elevated Pulmonary Artery Pressure.
    Nagel C; Marra AM; Benjamin N; Blank N; Cittadini A; Coghlan G; Distler O; Denton CP; Egenlauf B; Fiehn C; Fischer C; Harutyunova S; Hoeper MM; Lorenz HM; Xanthouli P; Bossone E; Grünig E
    Arthritis Rheumatol; 2019 May; 71(5):805-816. PubMed ID: 30615302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Echocardiographic Predictors for Worsening of Six-Minute Walk Distances in Patients With Systemic Sclerosis (Scleroderma).
    Kusunose K; Yamada H; Nishio S; Hirata Y; Seno H; Saijo Y; Ise T; Tobiume T; Yamaguchi K; Yagi S; Soeki T; Wakatsuki T; Sata M
    Am J Cardiol; 2017 Jul; 120(2):315-321. PubMed ID: 28532772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.